Bafna Pharmaceuticals Limited
NSE: BAFNAPH | Information Technology
Market Fundamentals
Stock Intelligence & News
Bafna Pharmaceuticals Limited
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Bafna Pharmaceuticals Limited
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bafna Pharmaceuticals Limited has submitted their response. |SUBJECT: Price movement
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026, in which the Board of Directors has inter-alia considered and approved: (i). The appointment of M/s. K. S. Rao & Co., Chartered Accountants, Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii). The appointment of M/s. N. Sivashankaran & Co., Cost Accountants, Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027 |SUBJECT: Outcome of Board Meeting
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Bafna Pharmaceuticals Limited
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Bafna Pharmaceuticals Limited
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bafna Pharmaceuticals Limited has submitted their response. |SUBJECT: Price movement
Read Full Analysis →Fixed income investments look attractive amid market volatility, says Basant Bafna
Investors are finding fixed income attractive amid market volatility. Basant Bafna of Mirae Asset Mutual Fund highlights appealing spreads and carry advantages. Inflows into fixed income funds are noted. The short-term outlook suggests curve steepening. Medium to long-term inflation is expected to remain anchored near 4%. Non-sovereign fixed income instruments appear particularly appealing.
Read Full Analysis →Get instant alerts when BAFNAPH breaks news
Join investors who track Bafna Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BAFNAPH?
BAFNAPH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Bafna Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BAFNAPH to your custom watchlist.